Medical Advocates

Pegylated Interferon Alfa-2a
(Pegasys)
 
Hepatic Disease Main Page

New and Noteworthy
Hepatitis B
Hepatitis C
HIV
HIV/HBV
HIV/HCV


 
 

HCV Drugs   Main New/Newsworthy  Home Page

Last Update:  March 27, 2018
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

New and Noteworthy
     

March 2018
 

HIV
 

      Journal Papers, Abstracts, and Commentaries
 
  Peginterferon α-2a for the Treatment of HIV Infection.
Asmuth DM, Utay NS, Pollard RB.  
Expert Opin Investig Drugs
. 2015 Dec 15
Abstract

Safety, Tolerability, and Mechanisms of Antiretroviral Activity of Pegylated Interferon
Alfa-2a in HIV-1-Monoinfected Participants: A Phase II Clinical Trial.
Asmuth DM, Murphy RL, Rosenkranz SL, et al
J Infect Dis. 2010 Apr 26
Abstract


HCV Drugs   Main New/Newsworthy  Home Page

Pegylated Interferon alfa-2a
Hepatic Disease Main Page